Clinical Trials Logo

Clinical Trial Summary

Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. It is believed that functional brain network analyses have the potential to identify individuals that may benefit from interventions prior to the development of irreversible white matter lesions. The current project will assess both physical and cognitive function and integrate these variables with measures of brain network connectivity.


Clinical Trial Description

Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. The preliminary data show that directly assessed patterns of functional connectivity correlate with mobility function and can be changed by interventions that improve mobility function. It is not known how changes in CNS functional connectivity relate to changes in mobility, information critical for the design of interventions targeting CNS connectivity to improve mobility impairments. It is clear that structural connectivity underlies functional connectivity, and that structural brain lesions result in altered functional connections. B-NET will assess white matter (WM) disease burden and microstructural changes and relate these changes to functional brain network connectivity. We hypothesize that because sensory motor cortex community structure (SMC-CS) characterizes current brain organization, it will be associated with mobility function independently of anatomical damage markers. Such knowledge may permit earlier identification of persons at high risk for mobility decline and facilitate earlier and better targeted interventions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03430427
Study type Observational
Source Wake Forest University Health Sciences
Contact
Status Completed
Phase
Start date July 20, 2018
Completion date July 12, 2023

See also
  Status Clinical Trial Phase
Completed NCT04014491 - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome N/A
Terminated NCT01006109 - Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
Recruiting NCT02559752 - Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT01531920 - A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel Phase 1
Completed NCT02652260 - Effects of Switching From ATRIPLAâ„¢ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Phase 2
Recruiting NCT01541800 - Circulating microRNAs as Disease Markers in Pediatric Cancers N/A
Completed NCT02343718 - Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Phase 1
Completed NCT03830762 - Xanamemâ„¢ in Healthy Elderly Subjects Phase 1
Completed NCT01527006 - Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs Phase 2
Completed NCT01517087 - Studying Motor Neuron Tests
Recruiting NCT05627986 - Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Completed NCT01432288 - Touch and Attention MRI Study N/A
Completed NCT00067067 - Investigating Endothelial Precursor Cells (EPCs) N/A
Completed NCT03268239 - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions N/A
Recruiting NCT04846764 - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM) N/A